Revamp CKD Anemia Care: A Tailored Approach

This article is brought to you by Cresp

Personalized treatment strategy in CKD Anemia

Factors affecting choice of oral or IV iron in iron deficiency treatment in non-dialysis patient

Abbreviations ▼

CKD: Chronic kidney disease; ESA: Erythropoiesis stimulating agent; Hb: Haemoglobin; HIF-PHI: Hypoxia-inducible factor–prolyl hydroxylase inhibitor; IV: Intravenous; TSAT: Transferrin saturation; CHr: Reticulocyte Haemoglobin Content; CRP: C-reactive protein; %HRC: Percent Reticulocyte Haemoglobin Content; IL-6: Interleukin 6; LDH: Lactate dehydrogenase; PTH: Parathyroid hormone; SC: Subcutaneous.

References ▼

Macdougall IC. Anaemia in CKD—treatment standard.Nephrol Dial Transplant. 2024;39(5):770–777.

LMRC Code: GGI-CO-A1-AQS-300027678-BANNERS-G24-0782

Cresp 1

Cresp®(Biosimilar of darbepoetin alpha), a product by Dr. Reddy's is an erythropoiesis-stimulating agent which helps in treatment of renal anemia in pre-dialysis patients

Know more

Revamp CKD Anemia Care: A Tailored Approach

Revamp CKD Anemia Care: A Tailored Approach, Cresp, Docvidya, Nephrology, Nephrologist, Anemia, Chronic Kidney Disease, Iron deficiency

Related Articles

Login to continue